Asia’s Medicinal Cannabis Market Could Be Worth Over $US5.8 Billion by 2024 – Prohibition Partners

Cannabis, Life Science

Pulmonx Closes $65 Million Financing and Adds Chief Financial Officer

Life Science

Innovative Cellular Presents Data on Novel CD19 CAR-T Therapy

Life Science

Viva Biotech Completes $194 Million Hong Kong IPO; Trades Higher

Life Science

Takeda Divests Eye Drug to Novartis for $5.3 Billion

Life Science

Merck to Invest $1 Billion in Virginia Facility, Add 100 Jobs

Life Science

InnoCare Planning $250 Million IPO on Hong Kong Exchange

Life Science

VolitionRx Limited Executes a Contract for Clinical Trial Program in Lung Cancer

Life Science

MORE Health Announces Strategic Collaboration with Beijing Henghe Hospital

Life Science

India’s Alembic Pharma Forms JV to Market Generics in China

Life Science

GeneQuantum Raises $15 Million for Novel ADC Drug Discovery

Life Science

China News Weekly 109 – China’s Meichen Partners Australian Firm to Grow Industrial Hemp

Life Science, Mining, Technology

Harbour BioMed and Chia Tai Tianqing Pharmaceutical Group Ltd. Announce Strategic Alliance to Discover, Develop and Commercialize Innovative Biologics

Life Science

China’s Meichen Partners Australian Firm to Grow Industrial Hemp

Cannabis, Life Science

TAKE2 Health In-licenses IP for Nasopharyngeal Cancer Blood Test

Life Science